Literature DB >> 34942118

Life of RISC: Formation, action, and degradation of RNA-induced silencing complex.

Hiro-Oki Iwakawa1, Yukihide Tomari2.   

Abstract

Small RNAs regulate a wide variety of biological processes by repressing the expression of target genes at the transcriptional and post-transcriptional levels. To achieve these functions, small RNAs form RNA-induced silencing complex (RISC) together with a member of the Argonaute (AGO) protein family. RISC is directed by its bound small RNA to target complementary RNAs and represses their expression through mRNA cleavage, degradation, and/or translational repression. Many different factors fine-tune RISC activity and stability-from guide-target RNA complementarity to the recruitment of other protein partners to post-translational modifications of RISC itself. Here, we review recent progress in understanding RISC formation, action, and degradation, and discuss new, intriguing questions in the field.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34942118     DOI: 10.1016/j.molcel.2021.11.026

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  11 in total

Review 1.  Histopathology and molecular pathology of pediatric pineal parenchymal tumors.

Authors:  Alexandre Vasiljevic
Journal:  Childs Nerv Syst       Date:  2022-08-16       Impact factor: 1.532

2.  Structure of the Dicer-2-R2D2 heterodimer bound to a small RNA duplex.

Authors:  Sonomi Yamaguchi; Masahiro Naganuma; Tomohiro Nishizawa; Tsukasa Kusakizako; Yukihide Tomari; Hiroshi Nishimasu; Osamu Nureki
Journal:  Nature       Date:  2022-06-29       Impact factor: 69.504

3.  Tracking miR-17-5p Levels following Expression of Seven Reported Target mRNAs.

Authors:  Kevin Y Du; Javeria Qadir; Burton B Yang; Albert J Yee; Weining Yang
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

Review 4.  An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.

Authors:  Mina Roueinfar; Hayley N Templeton; Julietta A Sheng; Ka Lok Hong
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

5.  Characteristics of Transfer RNA-Derived Fragments Expressed during Human Renal Cell Development: The Role of Dicer in tRF Biogenesis.

Authors:  Marek Kazimierczyk; Marta Wojnicka; Ewa Biała; Paulina Żydowicz-Machtel; Barbara Imiołczyk; Tomasz Ostrowski; Anna Kurzyńska-Kokorniak; Jan Wrzesinski
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

Review 6.  Current Advances in RNA Therapeutics for Human Diseases.

Authors:  Hannah Zogg; Rajan Singh; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-03-01       Impact factor: 5.923

Review 7.  The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives.

Authors:  Karolina Jałbrzykowska; Alicja Chrzanowska; Piotr Roszkowski; Marta Struga
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

8.  Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects.

Authors:  Abhilash Kannan; Maarit Suomalainen; Romain Volle; Michael Bauer; Marco Amsler; Hung V Trinh; Stefano Vavassori; Jana Pachlopnik Schmid; Guilherme Vilhena; Alberto Marín-González; Ruben Perez; Andrea Franceschini; Christian von Mering; Silvio Hemmi; Urs F Greber
Journal:  Viruses       Date:  2022-06-28       Impact factor: 5.818

9.  Optimized protocols for RNA-induced silencing complex assembly and cleavage in cultured Drosophila cells.

Authors:  Yajie Gao; Yuanxiang Zhu; Qinmiao Sun; Dahua Chen
Journal:  STAR Protoc       Date:  2022-07-31

Review 10.  Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route.

Authors:  Fengqian Chen; Qi Liu; Yang Xiong; Li Xu
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.